×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance
Biorestorative Therapies, Inc. (BRTX) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of...
18 hours ago
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q1 2024
InvestorPlace
BRTX stock results show that BioRestorative Therapies beat analyst estimates for earnings per share and beat on revenue for the first...
3 hours ago
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Tops Revenue Estimates
MSN
Biorestorative Therapies, Inc. (BRTX) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of...
16 hours ago
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
GlobeNewswire
MELVILLE, NY., June 04, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX),...
1 week ago
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
GlobeNewswire
MELVILLE, N.Y., May 24, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX),...
2 weeks ago
BioRestorative Therapies Provides First Quarter 2024 Business Update
Yahoo Finance
MELVILLE, N.Y., May 14, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX),...
1 month ago
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting ...
GlobeNewswire
New therapeutic candidate developed using Company's patented ThermoStem® platform — — Candidate has potential to serve as an adjuvant to...
1 month ago
BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in ...
Yahoo Finance
Leading regenerative medicine and aesthetics innovators collaborate to build a vertically integrated, best-in-class biocosmeceutical...
1 month ago
BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Yahoo Finance
Company to provide update on exciting new commercial agreement, as well as Phase 2 clinical trial in Spine and preclinical development...
1 month ago
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc ...
GlobeNewswire
Preliminary data includes 26 and 52-week follow-up end points as part of ongoing Phase 2 trial — — Company to host webcasted conference call...
4 months ago